Core Diagnostics, Digistain collaborate to bring breast cancer risk profiling technology to India, Nepal, Bhutan, Bangladesh – ET HealthWorld
Gurugram: Core Diagnostics announced its exclusive partnership with Digistain. The collaboration aims to bring the breast cancer risk profiling technology, Digistain, to India, Nepal, Bhutan and Bangladesh. Digistain is a digital solution for cancer grading and prognosis, approved by the UK’s Medicines & Healthcare products Regulatory Agency (MHRA). It offers a rapid, affordable, and AI-enabled … Read more